|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 06/05/14 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
| 06/05/14 | Actavis : M&A frenzy in healthcare sector | RE |
Company details: Forest Laboratories, Inc.
Forest Laboratories, Inc.
909 Third Avenue
10022-4731, New York
+212-421-7850
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.02% | +1.28% | +52.14% | +92.40% | 994B | |
| +0.28% | -1.04% | +50.12% | +62.65% | 640B | |
| +1.81% | +5.22% | +20.29% | +70.38% | 454B | |
| +5.00% | +1.23% | +36.64% | +40.84% | 337B | |
| +1.68% | -12.09% | +15.25% | +26.83% | 261B | |
| +3.81% | +1.23% | +3.05% | +14.86% | 246B | |
| +1.10% | -2.97% | +39.03% | +45.44% | 204B | |
| +1.43% | -6.19% | -19.49% | -58.38% | 190B | |
| +1.87% | -0.16% | +30.10% | +89.26% | 178B | |
| Average | +2.09% | -5.76% | +25.24% | +42.70% | 389.42B | |
| Weighted average by Cap. | +2.02% | -4.42% | +34.20% | +57.78% |
- Stock Market
- Stocks
- Stock
- Company Forest Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
